Hanson & Doremus Investment Management Amgen Inc Transaction History

Hanson & Doremus Investment Management

$595 Million
Q2 2024

A detailed history of Hanson & Doremus Investment Management transactions in Amgen Inc stock. As of the latest transaction made, Hanson & Doremus Investment Management holds 1,592 shares of AMGN stock, worth $508,007. This represents 0.08% of its overall portfolio holdings.

Number of Shares

1,592

Previous 1,537 3.58%

Holding current value

$508,007

Previous $437,000 13.73%

% of portfolio

0.08%

Previous 0.08%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$262.75 - $319.31 $14,451 - $17,562	55 Added 3.58%	1,592 $497,000
Q1 2024 Apr 22, 2024	BUY	$268.87 - $324.56 $26,349 - $31,806	98 Added 6.81%	1,537 $437,000
Q1 2023 Apr 18, 2023	SELL	$225.79 - $275.2 $78,574 - $95,769	-348 Reduced 19.47%	1,439 $347,000
Q4 2022 Jan 18, 2023	BUY	$229.03 - $291.01 $79,702 - $101,271	348 Added 24.18%	1,787 $469,000
Q1 2022 Apr 22, 2022	BUY	$219.27 - $242.57 $129,369 - $143,116	590 Added 69.49%	1,439 $348,000
Q3 2021 Oct 21, 2021	SELL	$212.27 - $248.7 $4,245 - $4,974	-20 Reduced 2.3%	849 $180,000
Q2 2021 Jul 22, 2021	SELL	$233.58 - $259.14 $22,423 - $24,877	-96 Reduced 9.95%	869 $221,000
Q1 2021 May 03, 2021	BUY	$221.91 - $258.6 $3,550 - $4,137	16 Added 1.69%	965 $240,000
Q4 2020 Feb 01, 2021	BUY	$216.38 - $257.67 $17,310 - $20,613	80 Added 9.21%	949 $218,000
Q2 2020 Jul 17, 2020	SELL	$197.81 - $242.74 $15,824 - $19,419	-80 Reduced 8.43%	869 $205,000
Q1 2020 Apr 24, 2020	BUY	$182.24 - $241.7 $3,098 - $4,108	17 Added 1.82%	949 $192,000
Q4 2019 Jan 16, 2020	SELL	$189.21 - $243.2 $15,893 - $20,428	-84 Reduced 8.27%	932 $225,000
Q3 2019 Oct 18, 2019	SELL	$174.11 - $208.62 $15,495 - $18,567	-89 Reduced 8.05%	1,016 $197,000
Q1 2019 Apr 23, 2019	BUY	$180.87 - $203.88 $8,139 - $9,174	45 Added 4.25%	1,105 $0
Q3 2018 Oct 24, 2018	SELL	$185.29 - $208.89 $17,973 - $20,262	-97 Reduced 8.38%	1,060 $0
Q2 2018 Aug 08, 2018	SELL	$166.05 - $186.51 $18,929 - $21,262	-114 Reduced 8.97%	1,157 $214,000
Q1 2018 May 10, 2018	BUY	$169.43 - $198.0 $13,554 - $15,840	80 Added 6.72%	1,271 $217,000
Q3 2017 Oct 26, 2017	BUY	$167.29 - $191.0 $199,242 - $227,481	1,191	1,191 $0

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hanson & Doremus Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Hanson & Doremus Investment Management with notifications on news.

Account

Hanson & Doremus Investment Management Amgen Inc Transaction History